Article

Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d

medRxiv · 2021 · Almeida, C. F.; Smith, D.; Cheng, T.-Y.; Harpur, C.; Batleska, E.; Nguyen, T.; Hilmenyuk, T.; Nguyen-Robertson, C. V.; Reddiex, S. J.; Van Rhijn, I.; Rossjohn, J.; Uldrich, A. P.; Moody, B.; Williams, S. J.; Pellicci, D. G.; Godfrey, D. I.

Key facts

Title Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d
First author Almeida, C. F.; Smith, D.; Cheng, T.-Y.; Harpur, C.; Batleska, E.; Nguyen, T.; Hilmenyuk, T.; Nguyen-Robertson, C. V.; Reddiex, S. J.; Van Rhijn, I.; Rossjohn, J.; Uldrich, A. P.; Moody, B.; Williams, S. J.; Pellicci, D. G.; Godfrey, D. I.
Journal medRxiv
Published Mar 6, 2021
DOI 10.1101/2021.03.05.433980
Devices mentioned BK110039, K103302
Product codes mentioned KIT, MVU, NJT, OOI, NDS, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature